CORRECTED: Pfizer, Prot@gen Sign on for Compugen s Proteomics Software | GenomeWeb

This story has been corrected to clarify that Compugen received orders from Prot@gen and not Protogene.

NEW YORK, Dec 1 – Compugen said Friday it had received orders from Pfizer and Prot@gen of Germany for its Z3 proteomics software and expects to announce several more commercial users in the near future.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: a sequencing-based screen of Lyme disease-causing pathogen, the range of animals bitten by Anopheles darling mosquitoes in Peru, and more.

An NC State researcher is exploring the use of CRISPR-Cas3 as an anti-microbial, Gizmodo reports.

The Earth BioGenome Project plans to sequence all life on Earth, according to ScienceInsider.

For those who are concerned about Trump administration actions related to science, a new column in Scientific American has suggestions for ways to fight back.